Publication date: 
Fri., Sep. 14, 2018 1:45pm EDT ·

FDA Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender (Sept. 27 and 28)

The FDA Office of Women’s Health, in collaboration with the Center for Drug Evaluation and Research and Center for Tobacco Products, will be hosting a 2-day public meeting on Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender. The conference will include presentations by experts in the field of opioid and tobacco research, professional education, and clinical care on the biological (sex) and sociological (gender) influences on use, misuse, and recovery.

Publication date: 
Thu., Aug. 30, 2018 2:45pm EDT ·

Biosimilar Basics For Patients: What Patients Should Know About Biologics and Biosimilars

This brochure, prepared by the American Pharmacists Association, describes biologic medications and a type of biologic known as biosimilars, which are highly similar to biologics but may be less expensive for patients. The information is designed to help you make informed decisions about your health care treatment options.

Pages